Using health check data to investigate cognitive function in Aboriginal and Torres Strait Islanders living with diabetes in the Torres Strait, Australia.
cognition
complications of diabetes mellitus
indigenous peoples
Journal
Endocrinology, diabetes & metabolism
ISSN: 2398-9238
Titre abrégé: Endocrinol Diabetes Metab
Pays: England
ID NLM: 101732442
Informations de publication
Date de publication:
01 2022
01 2022
Historique:
revised:
11
08
2021
received:
30
06
2021
accepted:
14
08
2021
pubmed:
25
9
2021
medline:
15
3
2022
entrez:
24
9
2021
Statut:
ppublish
Résumé
Type 2 Diabetes (T2DM) has a subtle deleterious effect on cognition and imposes a higher lifetime risk of cognitive impairment and dementia. In populations where both T2DM and dementia are highly prevalent, understanding more about the early effects of T2DM on cognition may provide insights into the lifetime risks of this disease. In 2016, 186 Australian Aboriginal and/or Torres Strait Islander residents of the Torres Strait (54% female, mean age =38.9 years, SD =15.9, range =15-74) participated in a community health check. The effect of diabetes (Type 1 or Type 2) on speed of thinking and working memory was assessed with the Cogstate Brief Battery (CBB) during the health check. One third of participants had diabetes (n = 56, 30.1%). After adjusting for age, education and previous iPad/Tablet experience, participants with diabetes had a small, yet significant reduction in accuracy on the One Back working memory task (β = -.076, p = .010, r Early and subtle decrements in working memory may be a potential complication of diabetes among Aboriginal and Torres Strait Islander residents of the Torres Strait. Several potentially influential variables were not captured in this study (eg medication and diabetes duration). Greater preventative health resources are required for this population, particularly given the emerging elevated dementia rates linked to chronic disease.
Sections du résumé
BACKGROUND
Type 2 Diabetes (T2DM) has a subtle deleterious effect on cognition and imposes a higher lifetime risk of cognitive impairment and dementia. In populations where both T2DM and dementia are highly prevalent, understanding more about the early effects of T2DM on cognition may provide insights into the lifetime risks of this disease.
METHODS
In 2016, 186 Australian Aboriginal and/or Torres Strait Islander residents of the Torres Strait (54% female, mean age =38.9 years, SD =15.9, range =15-74) participated in a community health check. The effect of diabetes (Type 1 or Type 2) on speed of thinking and working memory was assessed with the Cogstate Brief Battery (CBB) during the health check.
RESULTS
One third of participants had diabetes (n = 56, 30.1%). After adjusting for age, education and previous iPad/Tablet experience, participants with diabetes had a small, yet significant reduction in accuracy on the One Back working memory task (β = -.076, p = .010, r
CONCLUSIONS
Early and subtle decrements in working memory may be a potential complication of diabetes among Aboriginal and Torres Strait Islander residents of the Torres Strait. Several potentially influential variables were not captured in this study (eg medication and diabetes duration). Greater preventative health resources are required for this population, particularly given the emerging elevated dementia rates linked to chronic disease.
Identifiants
pubmed: 34559471
doi: 10.1002/edm2.297
pmc: PMC8754245
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e00297Informations de copyright
© 2021 The Authors. Endocrinology, Diabetes & Metabolism published by John Wiley & Sons Ltd.
Références
BMC Psychol. 2013 Dec 23;1(1):30
pubmed: 25566378
Med J Aust. 2004 May 17;180(10):504-7
pubmed: 15139826
Med J Aust. 2014 May 5;200(8):465-9
pubmed: 24794609
Australas J Ageing. 2021 Jun;40(2):e125-e132
pubmed: 33169520
Prostaglandins Leukot Essent Fatty Acids. 2014 Dec;91(6):251-60
pubmed: 25451557
Endocrinol Diabetes Metab. 2022 Jan;5(1):e00297
pubmed: 34559471
J Clin Psychopharmacol. 2018 Oct;38(5):513-519
pubmed: 30124583
Alzheimers Dement. 2014 Nov;10(6):779-89
pubmed: 25458308
Curr Diab Rep. 2014;14(11):547
pubmed: 25273482
J Int Neuropsychol Soc. 2019 Feb;25(2):215-229
pubmed: 30575498
Nutr Neurosci. 2020 May;23(5):353-362
pubmed: 30073906
Med J Aust. 2010 May 17;192(10):562-5
pubmed: 20477730
J Epidemiol Glob Health. 2020 Mar;10(1):107-111
pubmed: 32175717
Annu Rev Psychol. 2013;64:135-68
pubmed: 23020641
Diabetes Res Clin Pract. 2006 Apr;72(1):93-9
pubmed: 16260061
Neurology. 2008 Nov 4;71(19):1470-3
pubmed: 18799785
Nat Rev Endocrinol. 2018 Oct;14(10):591-604
pubmed: 30022099
J Am Med Dir Assoc. 2016 Oct 1;17(10):889-95
pubmed: 27461866
Arch Clin Neuropsychol. 2020 Nov 19;35(8):1288-1302
pubmed: 32647858
Am J Geriatr Psychiatry. 2014 Oct;22(10):1055-9
pubmed: 24534521
Aust N Z J Psychiatry. 2010 Jul;44(7):631-9
pubmed: 20560850
BMC Psychol. 2017 Aug 2;5(1):26
pubmed: 28768522
Arch Neurol. 2012 Sep;69(9):1170-5
pubmed: 22710333
Med J Aust. 2019 Jul;211(1):24-30
pubmed: 31256439
Lancet Neurol. 2015 Mar;14(3):329-40
pubmed: 25728442
Neurobiol Dis. 2020 Feb;134:104608
pubmed: 31494283
Alzheimers Dement. 2015 Mar;11(3):271-9
pubmed: 24985534
Can J Diabetes. 2014 Dec;38(6):401-8
pubmed: 24933107
Med Care. 2003 May;41(5):582-92
pubmed: 12719681
Diabetologia. 2010 Nov;53(11):2298-306
pubmed: 20668831
J Int Neuropsychol Soc. 2014 Mar;20(3):278-91
pubmed: 24555960
Australas J Ageing. 2021 Aug 5;:
pubmed: 34351674
Lancet Diabetes Endocrinol. 2015 Jan;3(1):75-89
pubmed: 25163604